Maravai Lifesciences (MRVI) unit TriLink said Tuesday it has opened its Good Manufacturing Practice enzyme manufacturing facility in Jupiter, Florida.
The facility supports a coordinated supply of key RNA manufacturing and In Vitro Transcription workflow materials from early research through commercial production, the company said.
It is designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently, according to a statement.
Price: $5.02, Change: $+0.06, Percent Change: +1.21%